NKTR
Nektar Therapeutics
43.60$
-7.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.90 | 1.88 | 1.67 | 1.69 | 1.73 | 2.05 | 0.74 | 0.79 | 0.84 | 1.07 | 0.44 | 0.31 | 1.65 | |
| 0.98 | 0.57 | 0.66 | 0.70 | 0.32 | 0.56 | 0.03 | 0.02 | 0.01 | 0.00 | 0.01 | – | – | |
| 0.92 | 1.30 | 1.01 | 0.99 | 1.41 | 1.49 | 0.74 | 0.79 | 0.82 | 1.07 | 0.43 | 0.31 | 1.64 | |
| 1.90 | 2.35 | 2.11 | 2.14 | 2.51 | 2.02 | 2.17 | 2.12 | 1.93 | 1.46 | 1.44 | 1.18 | 3.99 | |
| 1.67 | 1.36 | 1.55 | 1.47 | 1.36 | 1.20 | 1.73 | 1.21 | 1.13 | 0.56 | 0.54 | 0.39 | 1.62 | |
| 4.46 | 3.93 | 3.74 | 4.56 | 3.87 | 0.48 | 3.91 | 3.37 | 3.06 | 2.01 | 1.98 | 1.59 | 5.61 | |
| -3.53 | -2.63 | -2.73 | -3.58 | -2.46 | 1.01 | -3.17 | -2.57 | -2.24 | -0.94 | -1.55 | -1.28 | -3.97 | |
| 0.47 | 0.54 | 0.43 | 0.46 | 0.43 | 0.71 | 0.35 | 0.38 | 0.43 | 0.48 | 0.32 | 0.22 | 0.94 | |
| -3.62 | -3.31 | -2.84 | -3.76 | -2.66 | 0.49 | -3.61 | -2.97 | -2.52 | -1.78 | -1.81 | -1.22 | -4.74 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -3.61 | -3.30 | -2.83 | -3.76 | -2.66 | 0.51 | -3.62 | -2.95 | -2.52 | -1.78 | -1.82 | -1.23 | -4.75 | |
| -3.02 | -2.64 | -2.29 | -3.19 | -2.15 | 1.23 | -2.91 | -2.40 | -2.08 | -1.29 | -1.49 | -1.28 | -4.07 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.